Cargando…

Long-lasting multifunctional CD8(+) T cell responses in end-stage melanoma patients can be induced by dendritic cell vaccination

Cytotoxic T cells are considered crucial for antitumor immunity and their induction is the aim of various immunotherapeutic strategies. High frequencies of tumor-specific CD8(+) T cells alone, however, are no guarantee for long-term tumor control. Here, we analyzed the functionality of tumor-specifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wimmers, Florian, Aarntzen, Erik H. J. G., Duiveman-deBoer, Tjitske, Figdor, Carl G., Jacobs, Joannes F. M., Tel, Jurjen, de Vries, I. Jolanda M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760336/ https://www.ncbi.nlm.nih.gov/pubmed/26942087 http://dx.doi.org/10.1080/2162402X.2015.1067745

Ejemplares similares

Early predictive value of multifunctional skin-infiltrating lymphocytes in anticancer immunotherapy
por: Wimmers, Florian, et al.
Publicado: (2014)

Naturally circulating dendritic cells to vaccinate cancer patients
por: Bol, Kalijn F., et al.
Publicado: (2013)

Harnessing human plasmacytoid dendritic cells as professional APCs
por: Tel, Jurjen, et al.
Publicado: (2012)

Tumoricidal activity of human dendritic cells
por: Tel, Jurjen, et al.
Publicado: (2014)

Eradicating cancer cells: struggle with a chameleon
por: Di, Jiabo, et al.
Publicado: (2011)

Single-cell analysis reveals that stochasticity and paracrine signaling control interferon-alpha production by plasmacytoid dendritic cells
por: Wimmers, Florian, et al.
Publicado: (2018)

A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets
por: Sittig, Simone P., et al.
Publicado: (2016)

Proteomics of Human Dendritic Cell Subsets Reveals Subset-Specific Surface Markers and Differential Inflammasome Function
por: Worah, Kuntal, et al.
Publicado: (2016)

Importance of helper T-cell activation in dendritic cell-based anticancer immunotherapy
por: Schreibelt, Gerty, et al.
Publicado: (2013)

Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets
por: Wimmers, Florian, et al.
Publicado: (2014)

Reducing cell number improves the homing of dendritic cells to lymph nodes upon intradermal vaccination
por: Aarntzen, Erik HJG, et al.
Publicado: (2013)

Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition
por: Tel, Jurjen, et al.
Publicado: (2016)

Functional OCT4-specific CD4(+) and CD8(+) T cells in healthy controls and ovarian cancer patients
por: Di, Jiabo, et al.
Publicado: (2013)

Dendritic Cells as Vaccines: Key Regulators of Tolerance and Immunity
por: Tel, Jurjen, et al.
Publicado: (2016)

Dendritic cell vaccination and immune monitoring
por: Aarntzen, E. H. J. G., et al.
Publicado: (2008)

Controlling T-Cell Activation with Synthetic Dendritic Cells Using the Multivalency Effect
por: Hammink, Roel, et al.
Publicado: (2017)

Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients
por: Boudewijns, Steve, et al.
Publicado: (2016)

Human CD1c(+) DCs are critical cellular mediators of immune responses induced by immunogenic cell death
por: Di Blasio, Stefania, et al.
Publicado: (2016)

Adjuvant dendritic cell vaccination in high-risk uveal melanoma patients
por: Bol, Kalijn, et al.
Publicado: (2015)

Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells
por: Eggermont, Loek J., et al.
Publicado: (2014)

The nature of activatory and tolerogenic dendritic cell-derived signal II
por: Bakdash, Ghaith, et al.
Publicado: (2013)

The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues
por: Tel, Jurjen, et al.
Publicado: (2011)

Skin-derived tumor specific T cells predict clinical outcome in dendritic cell vaccination studies in both stage III and IV melanoma patients
por: Aarntzen, EHJG, et al.
Publicado: (2010)

Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients
por: Bol, Kalijn F, et al.
Publicado: (2015)

Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E(2) results in high interleukin-12 production and cell migration
por: Boullart, A. C. Inge, et al.
Publicado: (2008)

Immune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients
por: Boudewijns, Steve, et al.
Publicado: (2016)

Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets
por: Sköld, Annette E., et al.
Publicado: (2015)

Survival of Ovarian Cancer Patients Is Independent of the Presence of DC and T Cell Subsets in Ascites
por: Wefers, Christina, et al.
Publicado: (2019)

Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4(+) T cells after FcγRII-mediated uptake
por: Benitez-Ribas, Daniel, et al.
Publicado: (2006)

Interleukin-15-Induced CD56(+) Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential
por: Anguille, Sébastien, et al.
Publicado: (2012)

Correction: Interleukin-15-Induced CD56(+) Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential
por: Anguille, Sébastien, et al.
Publicado: (2014)

CD56 marks human dendritic cell subsets with cytotoxic potential
por: Roothans, Dessie, et al.
Publicado: (2013)

Insight into the dynamics, localization and magnitude of antigen-specific immune responses by [(18)F]FLT PET imaging
por: Aarntzen, Erik H.J.G., et al.
Publicado: (2012)

A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients
por: Lesterhuis, W J, et al.
Publicado: (2010)

Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System
por: Wefers, Christina, et al.
Publicado: (2018)

Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination
por: Boudewijns, Steve, et al.
Publicado: (2016)

Humoral and cellular immune responses after influenza vaccination in patients with postcancer fatigue
por: Prinsen, Hetty, et al.
Publicado: (2015)

Immune infiltrates impact on the prediction of prognosis and response to immunotherapy of melanoma patients
por: Vasaturo, Angela, et al.
Publicado: (2015)

Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parameters
por: Aarntzen, Erik H. J. G., et al.
Publicado: (2012)

Harnessing RNA sequencing for global, unbiased evaluation of two new adjuvants for dendritic-cell immunotherapy
por: Mathan, Till S.M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hfsvfqc2m35fthoitseagspffq